Saturday 17 October 2026
Export DLB’s income statement to Excel — free account
Dolby Laboratories
DLB Industrials Specialty Business Services
Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024. In the quarter to June 2026, revenue fell 3.34%, EPS fell 37.5% and free cash flow grew 157.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.
59.95
0.88
−1.45%
Follow DLB
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to September
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | 30.38 | 45.13 | 58.17 | 56.09 | 44.68 | 83.10 | 61.55 | 70.26 | 66.35 | 64.02 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | 55.02 | 63.34 | 74.29 | 70.17 | 97.50 | 104.74 | 96.85 | 91.02 | 86.37 | 89.66 | |||||
| People | |||||||||||||||
| People | Employees | 2,030 | 2,122 | 2,151 | 2,193 | 2,289 | 2,368 | 2,336 | 2,246 | 2,080 | 2,051 | ||||
| Revenue/emp, $m | 0.51 | 0.51 | 0.49 | 0.57 | 0.51 | 0.54 | 0.54 | 0.58 | 0.61 | 0.66 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 1,026 | 1,080 | 1,055 | 1,242 | 1,162 | 1,281 | 1,254 | 1,300 | 1,274 | 1,349 | ||||
| Gross margin, % | 89.38 | 89.03 | 87.90 | 87.04 | 87.39 | 89.85 | 88.73 | 88.26 | 88.97 | 88.13 | |||||
| EBT | 236 | 255 | 196 | 282 | 240 | 355 | 215 | 250 | 312 | 303 | |||||
| EBT margin, % | 23.00 | 23.62 | 18.62 | 22.74 | 20.63 | 27.67 | 17.17 | 19.24 | 24.53 | 22.49 | |||||
| Net income | 186 | 207 | 42 | 256 | 232 | 318 | 184 | 202 | 264 | 256 | |||||
| Depreciation | 89 | 87 | 84 | 85 | 113 | 114 | 105 | 95 | 84 | 99 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 10.18 | 10.61 | 10.20 | 12.22 | 11.55 | 12.66 | 12.54 | 13.57 | 13.33 | 14.07 | ||||
| Earnings | 1.85 | 1.98 | 0.41 | 2.51 | 2.30 | 3.07 | 1.84 | 2.10 | 2.74 | 2.66 | |||||
| Cash flow | 3.58 | 3.71 | 3.41 | 3.22 | 3.42 | 4.42 | 3.19 | 3.83 | 3.43 | 4.93 | |||||
| Capex | (2.20) | (1.03) | (0.83) | (1.12) | (0.69) | (0.38) | (0.59) | (0.32) | (0.31) | (0.44) | |||||
| Free cash flow | 1.37 | 2.68 | 2.58 | 2.11 | 2.73 | 4.05 | 2.59 | 3.52 | 3.11 | 4.49 | |||||
| Book value | 19.65 | 21.06 | 22.93 | 22.76 | 24.25 | 25.74 | 22.51 | 24.77 | 26.03 | 27.45 | |||||
| Shares, m | 101 | 102 | 103 | 102 | 101 | 101 | 100 | 96 | 96 | 96 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 29.35 | 29.08 | 150.83 | 25.75 | 28.69 | 28.66 | 35.41 | 38.43 | 28.03 | 27.21 | ||||
| P/S | 5.33 | 5.45 | 6.79 | 5.29 | 5.74 | 6.95 | 5.20 | 5.95 | 5.74 | 5.14 | |||||
| P/B | 2.76 | 2.75 | 3.02 | 2.84 | 2.73 | 3.42 | 2.89 | 3.26 | 2.94 | 2.64 | |||||
| EV/Sales | 4.71 | 4.64 | 5.75 | 4.55 | 4.77 | 5.96 | 4.54 | 5.21 | 5.29 | 4.55 | |||||
| EV/FCF | 34.90 | 18.35 | 22.71 | 26.36 | 20.15 | 18.75 | 21.99 | 20.82 | 23.57 | 14.28 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 360 | 378 | 352 | 328 | 344 | 448 | 319 | 367 | 327 | 472 | ||||
| Capex | (222) | (105) | (85) | (114) | (69) | (38) | (59) | (30) | (30) | (42) | |||||
| Free cash flow | 138 | 273 | 267 | 214 | 275 | 410 | 259 | 337 | 297 | 430 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | 547 | 766 | 1,211 | 1,075 | 1,280 | 1,445 | 1,033 | 1,066 | 777 | 950 | ||||
| Total debt | — | — | — | — | 81 | 72 | 51 | 51 | — | — | |||||
| Net debt | (641) | (882) | (1,103) | (925) | (1,127) | (1,272) | (818) | (957) | (578) | (794) | |||||
| Shareholders’ equity | 1,979 | 2,144 | 2,371 | 2,313 | 2,438 | 2,604 | 2,251 | 2,372 | 2,487 | 2,632 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | 8.37 | 8.53 | 1.55 | 8.97 | 8.06 | 10.30 | 6.35 | 7.08 | 8.60 | 8.05 | ||||
| ROIC | 10.83 | 12.24 | 9.05 | 11.57 | 10.42 | 16.16 | 9.01 | 9.53 | 8.46 | 9.01 | |||||
| ROE | 9.80 | 10.02 | 1.85 | 10.90 | 9.74 | 12.30 | 7.58 | 8.68 | 10.78 | 9.96 | |||||
Negative figures in brackets.
Fiscal years to Sep 2025 · latest quarter Jun 2026
Charts ten years each
Dolby Laboratories vs peers in Specialty Business Services (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| RTO Rentokil Initial PLC | $10.5B | 61.8× | 29.4× | +66.96% (above 0%: growing) | +6.36% (above 0%: growing) | +7.92% (above 0%: growing) | 13.59% | 0.00% | Compare |
| DLB Dolby Laboratories | $5.7B | 25.2× | 16.5× | −3.34% (below 0%: shrinking) | −37.50% (below 0%: shrinking) | +157.37% (above 0%: growing) | 86.78% | 11.25% | |
| AMTM Amentum Holdings, Inc. | $4.7B | 23.5× | 21.9× | −1.99% (below 0%: shrinking) | +575.00% (above 0%: growing) | +35.00% (above 0%: growing) | 10.32% | 4.93% | Compare |
| UNF Unifirst Corporation | $4.6B | 39.7× | 39.4× | +3.87% (above 0%: growing) | −48.20% (below 0%: shrinking) | −21.68% (below 0%: shrinking) | 37.00% | 3.63% | Compare |
| AZZ AZZ Inc. | $3.9B | 23.2× | 22.1× | +16.68% (above 0%: growing) | −34.39% (below 0%: shrinking) | +115.52% (above 0%: growing) | 25.08% | 17.21% | Compare |
| FA First Advantage Corporation | $3.5B | 132× | 67.8× | +14.88% (above 0%: growing) | +5,455.56% (above 0%: growing) | +120.17% (above 0%: growing) | 45.46% | 12.71% | Compare |
| MMS Maximus, Inc. | $3.2B | 9.0× | 8.1× | −5.15% (below 0%: shrinking) | +4.81% (above 0%: growing) | +30.90% (above 0%: growing) | 27.27% | 12.62% | Compare |
| CBZ CBIZ, Inc. | $3.0B | 25.6× | 12.1× | −0.19% (below 0%: shrinking) | −53.03% (below 0%: shrinking) | +32.13% (above 0%: growing) | 10.62% | 4.99% | Compare |
| ABM ABM Industries Incorporated | $3.0B | 18.4× | 12.2× | +4.19% (above 0%: growing) | +25.37% (above 0%: growing) | −13.91% (below 0%: shrinking) | 12.35% | 3.95% | Compare |
| Median of peers | $3.7B | 24.6× | 22.0× | +4.03% | +5.59% | +31.52% | 19.34% | 4.96% |
Dolby Laboratories (DLB) key facts
- Strength: Dolby Laboratories' revenue for fiscal 2025 (year ended September 2025) was $1.3 billion, up 5.92% from fiscal 2024.
- Dolby Laboratories (DLB) is a Specialty Business Services company in the Industrials sector, listed on the New York Stock Exchange.
- As of October 16, 2026, DLB traded at $59.95, a market capitalization of $5.7 billion.
- Dolby Laboratories pays an annual dividend of $1.44 per share, a yield of 2.40%, with a payout ratio of 61.3%.
- Return on equity was 9.96% and debt-to-equity 0.00.
- Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 9.17 (safe zone) for fiscal 2025.